Glycogenosis type II is a multisystem disorder that requires management by a multidisciplinary team. The team should include several specialists, such as a metabolic disease specialist or biochemical geneticist, cardiologist, pulmonologist, neurologist, neuromuscular specialist, intensivist, orthopedist, respiratory therapist, physical therapist, occupational therapist, otolaryngologist speech therapist, audiologist, genetic counselor, and a metabolic dietician, who, as a team, will be capable of addressing the different manifestations of the condition. Aspects of functional assessment, rehabilitation, nutritional management, care coordination, nursing, genetic counseling, prenatal diagnosis, and screening are discussed in this article. In addition, treatment of glycogenosis type II is reviewed with attention to emerging therapeutic options.

Management and treatment of glycogenosis type 2 / B., Bembi; E., Cerini; C., Danesino; M. A., Donati; S., Gasperini; L., Morandi; O., Musumeci; Parenti, Giancarlo; S., Ravaglia; F., Seidita; A., Toscano; A., Vianello. - In: NEUROLOGY. - ISSN 0028-3878. - STAMPA. - 71(2008), pp. S12-S36.

Management and treatment of glycogenosis type 2

PARENTI, GIANCARLO;
2008

Abstract

Glycogenosis type II is a multisystem disorder that requires management by a multidisciplinary team. The team should include several specialists, such as a metabolic disease specialist or biochemical geneticist, cardiologist, pulmonologist, neurologist, neuromuscular specialist, intensivist, orthopedist, respiratory therapist, physical therapist, occupational therapist, otolaryngologist speech therapist, audiologist, genetic counselor, and a metabolic dietician, who, as a team, will be capable of addressing the different manifestations of the condition. Aspects of functional assessment, rehabilitation, nutritional management, care coordination, nursing, genetic counseling, prenatal diagnosis, and screening are discussed in this article. In addition, treatment of glycogenosis type II is reviewed with attention to emerging therapeutic options.
2008
Management and treatment of glycogenosis type 2 / B., Bembi; E., Cerini; C., Danesino; M. A., Donati; S., Gasperini; L., Morandi; O., Musumeci; Parenti, Giancarlo; S., Ravaglia; F., Seidita; A., Toscano; A., Vianello. - In: NEUROLOGY. - ISSN 0028-3878. - STAMPA. - 71(2008), pp. S12-S36.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/335644
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact